American Century Companies Inc. purchased a new stake in Imperva, Inc. (NASDAQ:IMPV) during the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 157,419 shares of the software maker’s stock, valued at approximately $6,832,000. American Century Companies Inc. owned about 0.47% of Imperva as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Ameritas Investment Partners Inc. lifted its holdings in shares of Imperva by 18.7% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after acquiring an additional 464 shares in the last quarter. First Quadrant L P CA bought a new stake in shares of Imperva during the 3rd quarter valued at about $136,000. Migdal Insurance & Financial Holdings Ltd. grew its position in shares of Imperva by 26.2% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock valued at $201,000 after buying an additional 866 shares during the last quarter. Amalgamated Bank acquired a new position in Imperva during the 2nd quarter valued at about $206,000. Finally, Principal Financial Group Inc. acquired a new position in Imperva during the 2nd quarter valued at about $223,000. Institutional investors own 92.20% of the company’s stock.
WARNING: “American Century Companies Inc. Acquires Shares of 157,419 Imperva, Inc. (IMPV)” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://ledgergazette.com/2017/11/22/american-century-companies-inc-acquires-shares-of-157419-imperva-inc-impv.html.
In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the transaction, the director now owns 99,598 shares in the company, valued at $4,341,476.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.90% of the stock is owned by insiders.
A number of research firms recently commented on IMPV. Morgan Stanley reiterated an “underweight” rating and issued a $39.00 target price on shares of Imperva in a report on Thursday, November 9th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and set a $55.00 target price on shares of Imperva in a research report on Thursday, November 9th. Stifel Nicolaus reissued a “hold” rating and set a $47.00 price objective (down previously from $50.00) on shares of Imperva in a report on Thursday, November 9th. Evercore ISI reissued a “buy” rating and set a $56.00 price objective on shares of Imperva in a report on Wednesday, November 8th. Finally, Zacks Investment Research raised shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 price objective on the stock in a report on Tuesday, October 24th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. Imperva presently has a consensus rating of “Hold” and a consensus price target of $52.38.
Imperva, Inc. (NASDAQ IMPV) opened at $40.45 on Wednesday. Imperva, Inc. has a 52 week low of $35.45 and a 52 week high of $52.40.
Imperva (NASDAQ:IMPV) last issued its earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.22 by $0.11. The business had revenue of $83.89 million for the quarter, compared to analysts’ expectations of $83.79 million. Imperva had a negative return on equity of 8.52% and a net margin of 3.04%. The business’s revenue for the quarter was up 22.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.08 EPS. research analysts expect that Imperva, Inc. will post -0.52 EPS for the current year.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with MarketBeat.com's FREE daily email newsletter.